CHANNELS

Subscribe to the InfoTech eNewsletter

infoTECH News

TMCNet:  Research and Markets: Kidney Transplantation - Pipeline Review, H1 2014

[April 29, 2014]

Research and Markets: Kidney Transplantation - Pipeline Review, H1 2014

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/n8t9z6/kidney) has announced the addition of the "Kidney Transplantation - Pipeline Review, H1 2014" report to their offering.

This report provides comprehensive information on the therapeutic development for Kidney Transplantation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Kidney Transplantation and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class andbest-in-class products.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Kidney Transplantation
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Kidney Transplantation and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Kidney Transplantation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Kidney Transplantation pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Companies Mentioned

  • GlaxoSmithKline plc
  • Quark Pharmaceuticals, Inc.
  • Pharming Group N.V.
  • Astellas Pharma Inc.
  • Shire Plc
  • 4SC AG
  • Veloxis Pharmaceuticals A/S
  • NPS Pharmaceuticals, Inc.
  • La Jolla Pharmaceutical Company
  • Alexion Pharmaceuticals, Inc.
  • Hansa Medical AB
  • Digna Biotech, S.L.
  • Viron Therapeutics, Inc.
  • Opsona Therapeutics Ltd.
  • Angion Biomedica Corp.
  • NovImmune SA
  • Tolera Therapeutics, Inc.
  • Pharmicell Co., Ltd.

For more information visit http://www.researchandmarkets.com/research/n8t9z6/kidney


[ InfoTech Spotlight's Homepage ]


blog comments powered by Disqus

FOLLOW US

Subscribe to InfoTECH Spotlight eNews

InfoTECH Spotlight eNews delivers the latest news impacting technology in the IT industry each week. Sign up to receive FREE breaking news today!
FREE eNewsletter